Company Data
Regulus Therapeutics Inc.
Ticker
RGLS
Current Price
$8.16
Market Cap
$565.0M
Price Target
Refer to Report
Volume
285.3K
52wk Range
$0.8301 - $8.345
Overview
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.